Davidson Kevin R. 4
4 · BioDrain Medical, Inc. · Filed Jan 6, 2011
Insider Transaction Report
Form 4
Davidson Kevin R.
DirectorPresident, CEO and CFO
Transactions
- Award
Options
2010-11-16+800,000→ 800,000 totalExercise: $0.15From: 2010-11-16Exp: 2020-11-16→ Common stock (800,000 underlying) - Conversion
Convertible note
2009-10-31→ 0 totalExercise: $0.35From: 2009-10-31Exp: 2009-10-31→ Common stock (3,506 underlying) - Conversion
Common stock
2009-10-31$0.35/sh+3,506$1,227→ 333,434 total